Back to results
US 2006/0216276 A1Published application
Use of materials for treatment of central nervous system lesions
OwnerMari Dezawa, Keita Moriinventors
Life of this patent
Estimating the term…
Abstract
Disclosed are methods and materials for treatment of central nervous system lesions. Preferred methods and materials comprise neuronal precursor cells and/or marrow adherent stem cell-derived neuronal cells.
Claims33
A method comprising:
- providing neuronal precursor cells;
- and
- administering the neuronal precursor cells to a patient suffering from a central nervous system lesion in an amount sufficient to facilitate functional recovery of the patient.
A graft forming unit comprising:
- neuronal precursor cells present in an amount sufficient to facilitate functional recovery of a patient suffering from a central nervous system lesion following administration of the neuronal precursor cells to the patient;
- and
- a pharmaceutically acceptable carrier.
A method comprising:
- providing marrow-adherent stem cell-derived neuronal cells;
- and
- administering the marrow-adherent stem cell-derived neuronal cells to a patient suffering from a central nervous system lesion in an amount sufficient to facilitate functional recovery of the patient.
A graft forming unit comprising:
- marrow-adherent stem cell-derived neuronal cells present in an amount sufficient to facilitate functional recovery of a patient suffering from a central nervous system lesion following administration of the marrow-adherent stem cell-derived neuronal cells to the patient;
- and
- a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.